These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 2858225)

  • 21. Neuroleptic malignant syndrome and catatonia: one entity or two?
    Northoff G
    Biol Psychiatry; 1996 Sep; 40(5):431-3. PubMed ID: 8874850
    [No Abstract]   [Full Text] [Related]  

  • 22. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
    Lee JW; Robertson S
    Ann Clin Psychiatry; 1997 Sep; 9(3):165-9. PubMed ID: 9339882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catatonic and non-catatonic neuroleptic malignant syndrome.
    Lee JW
    Aust N Z J Psychiatry; 2000 Oct; 34(5):877-8. PubMed ID: 11037384
    [No Abstract]   [Full Text] [Related]  

  • 24. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuroleptic malignant syndrome: presentation and treatment.
    Birkhimer LJ; DeVane CL
    Drug Intell Clin Pharm; 1984 Jun; 18(6):462-5. PubMed ID: 6145570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome].
    Hirjak D; Sartorius A; Kubera KM; Wolf RC
    Nervenarzt; 2019 Jan; 90(1):12-24. PubMed ID: 30128733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catatonia: harbinger of the neuroleptic malignant syndrome.
    White DA; Robins AH
    Br J Psychiatry; 1991 Mar; 158():419-21. PubMed ID: 1674666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of lethal catatonia with dantrolene sodium.
    Stemp LI
    Crit Care Med; 1993 Sep; 21(9):1403. PubMed ID: 8240540
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant catatonia--a continuing reality.
    Singerman B; Raheja R
    Ann Clin Psychiatry; 1994 Dec; 6(4):259-66. PubMed ID: 7647836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute catatonia and neuroleptic malignant syndrome. A case of infantile psychosis].
    Revuelta E; Bordet R; Piquet T; Ghawche F; Destee A; Goudemand M
    Encephale; 1994; 20(3):351-4. PubMed ID: 7916282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings.
    Blumer D
    Compr Psychiatry; 1997; 38(4):193-201. PubMed ID: 9202876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General anesthesia after neuroleptic malignant syndrome.
    Lotstra F; Linkowski P; Mendlewicz J
    Biol Psychiatry; 1983 Feb; 18(2):243-7. PubMed ID: 6131703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and management of the neuroleptic malignant syndrome.
    Bond WS
    Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual catatonic state following neuroleptic malignant syndrome.
    Caroff SN; Mann SC; Keck PE; Francis A
    J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome.
    Strawn JR; Keck PE; Caroff SN
    Am J Psychiatry; 2007 Jun; 164(6):870-6. PubMed ID: 17541044
    [No Abstract]   [Full Text] [Related]  

  • 40. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
    Belteczki Z; Ujvari J; Dome P
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):148-153. PubMed ID: 34132673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.